UP!
| 2015-06-30 | Reiterated Rating | BMO Capital Markets | Market Perform | |
| 2015-06-29 | Reiterated Rating | HC Wainwright | Hold | |
| 2015-06-02 | Reiterated Rating | HC Wainwright | Hold | |
| 2015-05-15 | Reiterated Rating | HC Wainwright | Hold | |
| 2015-04-28 | Downgrade | HC Wainwright | Buy to Neutral | |
| 2015-04-27 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2015-04-27 | Downgrade | Wedbush | Outperform to Neutral | |
| 2015-04-27 | Downgrade | Roth Capital | Buy to Neutral | $2.00 |
| 2015-04-22 | Initiated Coverage | BMO Capital Markets | Market Perform to Market Perform | $15.00 to $15.00 |
| 2015-04-07 | Initiated Coverage | HC Wainwright | Buy | $31.00 |
| 2015-03-05 | Initiated Coverage | Roth Capital | Buy | $70.00 |
| 2014-10-13 | Initiated Coverage | Credit Suisse | Outperform | $20.00 |
| 2014-02-24 | Initiated Coverage | Barclays | Overweight | $15.00 |
| 2014-02-24 | Initiated Coverage | Stifel Nicolaus | Buy | $16.00 |
| 2014-02-24 | Initiated Coverage | Wedbush | Outperform | $17.00 |
| 2015-06-30 | Reiterated Rating | BMO Capital Markets | Market Perform | |
| 2015-06-29 | Reiterated Rating | HC Wainwright | Hold | |
| 2015-06-02 | Reiterated Rating | HC Wainwright | Hold | |
| 2015-05-15 | Reiterated Rating | HC Wainwright | Hold | |
| 2015-04-28 | Downgrade | HC Wainwright | Buy to Neutral |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CLDN 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Enterprise Partners Management LLC | 10.52% (1950184) | CLDN / |
| PFIZER INC | 9.68% (1794803) | AQXP / CLDN / FLXN / |
| Lundbeckfond Invest A/S | 9.42% (1745683) | CLDN / |
| Kordel Johan | 9.42% (1745683) | CLDN / |
| Novartis Bioventures Ltd | 8.37% (1551721) | AKBA / CLDN / MRNA / PIP / TKAI / |
| Funder Joshua | 6.44% (1194204) | CLDN / |
| Foley Todd | 5.76% (1066775) | CLDN / EPRS / PETX / |
| NARACHI MICHAEL | 0.34% (62500) | AMAG / CLDN / OREX / |
| Cory David A President and CEO | 0.32% (58451) | CLDN / |
| Glenn Jeffrey S | 0.17% (31355) | CLDN / |
| WIKLUND FREDRIK VP Corp Dvlpmnt & Invs Rltns | 0.11% (20000) | CLDN / |
| Shaffer James P Chief Business Officer | 0.03% (5620) | CLDN / HALO / |
| ZSEBO KRISZTINA M Chief Executive Officer | 0.02% (3125) | CLDN / |
| LABA REBECQUE J VP Finance & Administration | 0.02% (2895) | CLDN / |
| WELCH JAMES H Chief Financial Officer | 0.01% (2500) | ACRX / CLDN / |
| TAKEYA RYAN K VP, Manufacturing | 0.01% (1432) | CLDN / |
| RUDY JEFFREY J VP, Clinical Operations | 0.01% (1024) | CLDN / |
UM